BioSpain 2025, one of the most relevant biotechnology events in Europe, was held this year in Barcelona. HIPRA Biotech Services, the Contract Development and Manufacturing Organization (CDMO) of HIPRA, actively participated in this major event with its own stand, where it showcased its advanced solutions and services for the biotech industry.
The company took part in various activities within the framework of the congress. Among these, a highlight was the press conference dedicated to presenting the SPEEDCELL project to specialized industry media.

The session was led by Laura Ferrer, R&D Director for Human Health at HIPRA, and Eduard Viladesau, General Manager of HIPRA Biotech Services, who explained how SPEEDCELL is revolutionizing vaccine manufacturing.

The project, which aims to reduce vaccine production time to just 100 days, represents a significant leap forward in the automation and efficiency of biotechnological manufacturing processes. By integrating cutting-edge technologies and innovative production models, SPEEDCELL aspires to set a new standard in rapid vaccine development and contribute to global preparedness against emerging health threats.

HIPRA’s participation in BioSpain 2025 once again underscores its commitment to innovation, collaboration, and the advancement of biotechnology to improve health worldwide.